Latest News
Da Nang, Rendezvous for Aviation Leaders at Routes Asia 2022
DA NANG, Vietnam, June 6, 2022 /PRNewswire/ -- Taking place from June 6-8, 2022
, Routes Asia 2022 will bring together policy makers from airlines, airports,
and destinations and aviation suppliers to outline the actions that must be
taken to accelerate the region's recovery.
2022-06-06 10:51
3658
TVU Remote Commentator Platform Enables Live, Remote Sports Commentary Over IP for Mediacorp at the 31st Southeast Asian Games
First TVU Remote Commentator Deployment in Asia Pacific Region at Live Matches
of SEA Games 2022
SHANGHAI, June 6, 2022 /PRNewswire/ -- TVU Networks
2022-06-06 10:50
5514
Poster Highlighting Phase II Clinical Study of KN026 for HER2-expressing Advanced GC/GEJ Presented at 2022 ASCO
SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that data from a phase II clinical study of KN026 (HER2 bispecific antibody) monotherapy in patients with previously treated, advance...
2022-06-06 10:49
3539
OriCiro Announces Series B2 Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
TOKYO, June 5, 2022 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has closed Series B2 financing from Asahi Kasei Medical Co., Ltd. OriCiro has advanced its busine...
2022-06-06 10:09
2507
iValue Infosolutions named as GitHub Distributor for India and South-East-Asia Region
The partnership will expand GitHub's reach, enable developer collaboration, and
secure cloud-ready code with GitHub Enterprise
BENGALURU, India, June 6, 2022 /PRNewswire/ -- iValue InfoSolutions
2022-06-06 10:00
3576
Global Financial Expert, Mario Singh, Launched Two of His Best-Selling Books in Vietnamese
KINGSTOWN, Saint Vincent and the Grenadines, June 6, 2022 /PRNewswire/ -- Founder and Chairman of brokerage firm Fullerton Markets,Mario Singh, recently launched his masterworks, Unlocking the World's Largest Financial Secret and Secret Conversations with Trading Tycoons, in Vietnamese. Unlockin...
2022-06-06 10:00
3714
SCO Youth Technology and Innovation Forum concludes in Shenzhen
SHENZHEN, China, June 6, 2022 /PRNewswire/ -- A report from Jiandanshiji: The three-day Shanghai Cooperation Organization (SCO)Youth Technology and Innovation Forum dropped its curtain in Shenzhen, south China's Guangdong Province, on June 2. The Shenzhen Initiative on SCO Youth Technology and I...
2022-06-06 09:56
1883
Research Updates on KN046 Presented at 2022 ASCO
SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that research updates from four clinical studies of KN046 (PD-L1/CTLA-4 bispecific antibody) presented as a poster or published online at the 2022 American Society of Clinical Oncology Annual Meeting (20...
2022-06-06 09:47
3704
SocietyOne launches transaction & savings accounts powered by Westpac
SYDNEY, June 6, 2022 /PRNewswire/ -- In its first major corporate milestone
following its acquisition by MONEYME Ltd (ASX:MME), digital finance platform
SocietyOne has launched transaction and savings accounts powered by Westpac's
Banking-as-a-Service (BaaS).
2022-06-06 09:25
4215
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...
2022-06-06 09:00
2569
Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...
2022-06-06 09:00
2411
Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022
HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...
2022-06-06 09:00
2639
Anytime Fitness expanding world's largest and fastest-growing fitness club with three new clubs in Hong Kong
New branches in Ma On Shan Heng On Estate, Hung Hom and Fanling in first half of 2022 – brand targets 100 branches in 3-5 years HONG KONG, June 6, 2022 /PRNewswire/ -- Anytime Fitness is warming up for Hong Kong expansion of the world's largest and fastest-growing fitness club with the opening o...
2022-06-06 09:00
4301
MoneySmart Encourages Travellers to Have COVID-19 Travel Insurance as a Travel Essential
* High numbers of Singaporeans desire to travel abroad this year. * Singaporean travellers are encouraged to remain cautious about the COVID-19 virus and protect themselves with COVID-19 travel insurance. SINGAPORE, June 6, 2022 /PRNewswire/ -- Today's global travel scene is starting its retur...
2022-06-06 09:00
5608
SCO Youth Technology and Innovation Forum concludes in Shenzhen
BEIJING, June 6, 2022 /PRNewswire/ -- A news release from GLOBAL TIMES ONLINE: The three-day Shanghai Cooperation Organization (SCO)Youth Technology and Innovation Forum dropped its curtain in Shenzhen, south China's Guangdong Province, on June 2. The Shenzhen Initiative on SCO Youth Technology a...
2022-06-06 08:31
1886
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes
* WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (PFS) capacity to 17 million units per year. * WuXi Biologics has established a global manufacturing network with 9 drug p...
2022-06-06 08:30
5069
History Made In The Pho3nix Sub7 Sub8 Challenge
* Kristian Blummenfelt completes iron distance triathlon in the fastest men's time at 06:44:25 * Kat Matthews completes the distance in the fastest women's time at 07:31:54 * The Pho3nix Sub7 Sub8 Challenge, powered by Zwift aimed to encourage and inspire greater participation in sport am...
2022-06-06 08:25
3848
Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...
2022-06-06 08:08
4133
Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...
2022-06-06 08:00
4188
Innovent and IASO Bio Jointly Announce the NMPA Acceptance of the New Drug Application for Equecabtagene Autoleucel for the Treatment of Relapsed and/or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2022-06-06 08:00
4092
Week's Top Stories
Most Reposted
vVardis Raises $175 Million Ahead of NYSE IPO: NYSE Content Update
[Picked up by 1183 media titles]
2026-11-13 22:11
Cision Introduces AI-Powered Cision Intelligence to Help Brands See More and Act with Confidence
[Picked up by 1170 media titles]
2026-11-12 23:00
The NYSE Welcomes vVARDIS as a Publicly Listed Company
[Picked up by 1168 media titles]
2026-11-14 13:23
Cyient, 3-GIS Partner to Help Telecom and Utility Operators Turn Network Data into Operational Control
[Picked up by 1154 media titles]
2026-11-11 22:00Royal Bank of Canada announces agreement to acquire Yarra Capital Management
[Picked up by 1143 media titles]
2026-11-09 21:00Most Read
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
2026-11-13 13:00
132653
Royal Bank of Canada announces agreement to acquire Yarra Capital Management
2026-11-09 21:00
10284
Cision Report Reveals the Consumer Trends Hidden Between Search, Social, and AI
2026-11-09 23:00
9528
Poppi Founders Launch Hydration Brand jetty: NYSE Content Update
2026-11-10 22:17
7991
